Hydrophilic siloxanyl monomers with pendant polymerizable groups

1. A biomedical device comprising a polymerized monomer mixture of a monomer mix comprising

at least one monomer of formula (I)

wherein L can be the same or different and is selected from the group consisting of a bond, a straight or branched C1-C30 alkyl group, a C1-C30 fluoroalkyl group, a C1-C20 ester-containing group, an alkyl ether, cycloalkyl ether cycloalkenyl ether, aryl ether, arylalkyl ether, a polyether containing group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkylalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C5-C30 aryl group, a substituted or unsubstituted C5-C30 arylalkyl group, a substituted or unsubstituted C5-C30 heteroaryl group, a substituted or unsubstituted C3-C30 heterocyclic ring, a substituted or unsubstituted C4-C30 heterocyclolalkyl group, a substituted or unsubstituted C6-C30 heteroarylalkyl group, a C5-C30 fluoroaryl group, or a hydroxyl substituted alkyl ether and combinations thereof; A is a residue capable of forming organic acids, salts or esters selected from the group consisting of sulfonates, sulfates, sulfites, phosphates, phosphites, pyrophosphates and phosphonates; X is H, one equivalent alkali metal, or ½ equivalent alkaline earth metal; R is independently hydrogen, a straight or branched C1-C30 alkyl group, a C1-C30 fluoroalkyl group, a C1-C20 ester-containing group, an alkyl ether, cycloalkyl ether, cycloalkenyl ether, aryl ether, arylalkyl ether, a polyether containing group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkylalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C5-C30 aryl group, a substituted or unsubstituted C5-C30 arylalkyl group, a substituted or unsubstituted C5-C30 heteroaryl group, a substituted or unsubstituted C3-C30 heterocyclic ring, a substituted or unsubstituted C4-C30 heterocyclolalkyl group, a substituted or unsubstituted C6-C30 heteroarylalkyl group, fluorine, a C5-C30 fluoroaryl group, or a hydroxyl group; x and y are each at least 1; and V is independently a polymerizable ethylenically unsaturated organic radical;

and at least one second monomer.

2. The biomedical device of claim 1 wherein the device is a contact lens.

3. The biomedical device of claim 2 wherein the contact lens is a rigid gas permeable contact lens.

4. The biomedical device of claim 2 wherein the contact lens is soft contact lens.

5. The biomedical device of claim 2 wherein the contact lens is a hydrogel contact lens.

6. The biomedical device of claim 1 wherein the device is an intraocular lens.

7. The biomedical device of claim 6 wherein the intraocular lens is a phakic intraocular lens or an aphakic intraocular lens.

8. The biomedical device of claim 1 wherein the device is a corneal implant.

9. A biomedical device comprising a polymerization product of a monomer mixture comprising one or more monomers selected from the group consisting of the following formulae:

wherein x and y are each at least 1; and a second monomer.

10. The biomedical device of claim 9 wherein the device is a contact lens.

11. A method of making a biomedical device comprising:

providing a monomer mixture comprising the monomer of claim 1 and at least a second monomer;

subjecting the monomer mixture to polymerizing conditions to provide a polymerized device; and

extracting the unpolymerized monomers from the polymerized device.

12. The method of claim 11 wherein the step of extracting is performed with non-flammable solvents.

13. The method of claim 11 wherein the step of extracting is performed with water.

14. The method of claim 11 further comprising the step of packaging and sterilizing the polymerized device.